Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by ENDRA Life Sciences Inc.

< Previous 1 2 3 Next >
ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD’s The Liver Meeting® 2023
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
Abstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDA
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDA
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
Study Highlighting ENDRA Life Sciences’ TAEUS Technology to be Presented at EASL International Liver Congress 2023
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Report First Quarter 2023 Financial Results on May 15, 2023
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Securities
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 14, 2023
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Announces 1-for-20 Reverse Stock Split
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Report Third Quarter 2022 Financial Results on November 14, 2022
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of Two U.S. Patents
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Plans to Submit De Novo Request to U.S. FDA for its TAEUS® System in Coming Weeks
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Participate in Upcoming Investor and Industry Conferences
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Announces Issuance of 8th European Patent for its TAEUS® System
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Awarded Three Additional U.S. Patents for Cloud-enabled Connectivity of Medical Devices
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of 28th U.S. Patent
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
ENDRA Life Sciences to Participate in the JMP Securities Life Sciences Conference
From ENDRA Life Sciences Inc.
Via Business Wire
Tickers NDRA
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.